SteelPeak Wealth’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $916K | Buy |
2,808
+81
| +3% | +$26.4K | 0.04% | 265 |
|
|
2025
Q1 | $736K | Sell |
2,727
-753
| -22% | -$203K | 0.03% | 285 |
|
|
2024
Q4 | $819K | Buy |
3,480
+1,005
| +41% | +$236K | 0.03% | 262 |
|
|
2024
Q3 | $681K | Sell |
2,475
-1,071
| -30% | -$295K | 0.03% | 263 |
|
|
2024
Q2 | $862K | Sell |
3,546
-3,314
| -48% | -$805K | 0.04% | 234 |
|
|
2024
Q1 | $1.03M | Buy |
6,860
+4,090
| +148% | +$611K | 0.05% | 207 |
|
|
2023
Q4 | $530K | Sell |
2,770
-1,655
| -37% | -$317K | 0.03% | 260 |
|
|
2023
Q3 | $784K | Buy |
4,425
+1,408
| +47% | +$249K | 0.05% | 202 |
|
|
2023
Q2 | $573K | Buy |
3,017
+322
| +12% | +$61.2K | 0.03% | 223 |
|
|
2023
Q1 | $540K | Buy |
2,695
+276
| +11% | +$55.3K | 0.04% | 227 |
|
|
2022
Q4 | $575K | Sell |
2,419
-1,047
| -30% | -$249K | 0.04% | 224 |
|
|
2022
Q3 | $694K | Buy |
3,466
+9
| +0.3% | +$1.8K | 0.05% | 197 |
|
|
2022
Q2 | $504K | Buy |
+3,457
| New | +$504K | 0.04% | 248 |
|